Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Medical Data Vision Co's Cyclically Adjusted PS Ratio or its related term are showing as below:
TSE:3902'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.03 Med: 5.24 Max: 13.7
Current: 12.39
During the past 13 years, Medical Data Vision Co's highest Cyclically Adjusted PS Ratio was 13.70. The lowest was 3.03. And the median was 5.24.
TSE:3902's Cyclically Adjusted PS Ratio is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 1.19
vs TSE:3902: 12.39
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Medical Data Vision Co's adjusted revenue per share data of for the fiscal year that ended in Dec25 was 円172.733. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円135.91 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Medical Data Vision Co (TSE:3902) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Medical Data Vision Co Cyclically Adjusted PS Ratio Related Terms
Medical Data Vision Co Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for Medical Data Vision Co's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Data Vision Co Cyclically Adjusted PS Ratio Chart
TSE:3902 vs VEEV, TEM, BTSG: Cyclically Adjusted PS Ratio Comparison
For the Health Information Services subindustry, Medical Data Vision Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Data Vision Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Medical Data Vision Co's Cyclically Adjusted PS Ratio falls into.
Medical Data Vision Co Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 12.39 mean?
Medical Data Vision Co (TSE:3902) has a Cyclically Adjusted PS Ratio of 12.39 as of Aug. 14, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medical Data Vision Co and its competitors. This is 136% above median its historical median of 5.24. Over the past decade, Medical Data Vision Co's Cyclically Adjusted PS Ratio has ranged from 3.03 to 13.70.
Is Medical Data Vision Co's Cyclically Adjusted PS Ratio too high?
Medical Data Vision Co's current Cyclically Adjusted PS Ratio of 12.39 is 136% above median its 10-year median of 5.24. Over the past 10 years, this metric has ranged from a low of 3.03 to a high of 13.70. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.19. Medical Data Vision Co's value of 12.39 is 941.2% above this industry median. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's Cyclically Adjusted PS Ratio compare to VEEV and TEM?
Medical Data Vision Co's Cyclically Adjusted PS Ratio of 12.39 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cyclically Adjusted PS Ratio is 1.19. Medical Data Vision Co's value of 12.39 is 941.2% above this benchmark. Historically, Medical Data Vision Co's own Cyclically Adjusted PS Ratio has ranged from 3.03 to 13.70 over the past decade. While the company's 10-year median is 5.24 vs. the industry median of 1.19, Medical Data Vision Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.19, based on 360 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Data Vision Co's current Cyclically Adjusted PS Ratio of 12.39 is 941.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medical Data Vision Co and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Data Vision Co's current Cyclically Adjusted PS Ratio is 12.39, which is 136% above median its own 10-year median of 5.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current Cyclically Adjusted PS Ratio of 12.39. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 12.39, which is 136% above median its 10-year median of 5.24 and 941.2% above the Healthcare Providers & Services industry median of 1.19. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current Cyclically Adjusted PS Ratio is 12.39 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
Cyclically Adjusted PS Ratio: 12.39 (136% above median its 10-year median of 5.24)
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
Industry Position: 941.2% above the Healthcare Providers & Services median
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
